Skip to main content
. 2018 Aug 2;5(5):764–771. doi: 10.1002/ehf2.12333

Figure 1.

Figure 1

(A) Diagnostic and (B) treatment algorithms for iron deficiency in patients with chronic heart failure.1 *The use of ferric carboxymaltose has not been studied in children and is therefore not recommended in children under 14 years old. For full prescribing information, please refer to the summary of product characteristics.20 †The maximum dose per week of ferric carboxymaltose is 1000 mg. Two dosing sessions are required in case the patient needs >1000 mg ferric carboxymaltose.20 Algorithms adapted from Cappellini et al.1 and McDonagh and Macdougall.7 Hb, haemoglobin; i.v., intravenous; NYHA, New York Heart Association; TSAT, transferrin saturation.